Sensei Biotherapeutics, Inc. (SNSE) — Dilution Risk Analysis

Current Snapshot

Sensei Biotherapeutics, Inc. (SNSE) has a DilutionWatch score of 56/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
25,840,425 Source
Public Float
811,874 Source
Float as % of Outstanding
3.1%

Dilution Risk Score

Score: 56/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: S-3 1, 8-K 2, 4 4, XBRL 1, 3 2.

FormFiledAccession
S-3 2026-04-28 0001193125-26-183535
8-K 2026-04-16 0001193125-26-158951
4 2026-04-14 0001238120-26-000006
4 2026-04-14 0002038400-26-000001
xbrl 2026-03-31 xbrl-6059-xbrl_warrant
3 2026-02-19 0002111813-26-000003
4 2026-02-19 0002111813-26-000004
8-K 2026-02-18 0001193125-26-056135
3 2026-02-17 0001238120-26-000002
4 2026-02-17 0001238120-26-000004

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $200,000,000 Source
Cash runway 54 months Source
Three-year share count growth 1967.52% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 56/10) Source
Cash Runway
54 months Source
Shelf Registration Capacity
$200,000,000 Source
Share Count Growth (3-Year)
1967.52% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.